Tempo Therapeutics, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Tempo Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2024).
SEC Form D · Mar 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Tempo Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Westbrook Weaver | Executive officer | Mar 2024 |
| Steven Richieri | Executive officer | Jun 2020 |
| Biren Mehta | Director | Mar 2024 |
| Donald Griffin | Director | Mar 2024 |
| Richard Hancock | Director | Mar 2024 |
| Robin Sitver | Director | Mar 2024 |
| Steven Richieri | Director | Mar 2024 |
| Steven Sands | Director | Mar 2024 |
| Westbrook Weaver | Director | Mar 2024 |
| Dino Di Carlo | Director | Jun 2020 |
| Westbrook Weaver | Promoter | Jun 2020 |